The United States Food and Drug Administration on June 23, 2022, issued marketing denial orders to JUUL Labs Inc., for all of their products currently marketed in the United States, effectively banning the maker of e-cigarette devices and other vaping products from commercial sales and distribution.
Read the FDA’s full announcement here.
The products JUUL is ordered to stop selling include its popular electronic vaping device and four types of JUULpods: Virginia tobacco flavored pods at nicotine concentrations of 5.0% and 3.0% and mentholflavored pods at nicotine concentrations of 5.0% and 3.0%. All are popular with adolescents, a demographic reporting troubling spikes in addiction to nicotine concentrates.
“Today’s action is further progress on the FDA’s commitment to ensuring that all e-cigarette and electronic nicotine delivery system products currently being marketed to consumers meet our public health standards,” said FDA Commissioner Robert M. Califf, M.D., in a public statement. “The agency has dedicated significant resources to review products from the companies that account for most of the U.S. market. We recognize these make up a significant part of the available products and many have played a disproportionate role in the rise in youth vaping.”
Dr. Thurstone, director of Behavioral Health Services at Denver Health, recently spoke about the issue with Fox News 31 in Denver.